![]() |
Volumn 25, Issue 9, 2000, Pages 917-921
|
Natalizumab: Treatment of IBD treatment of multiple sclerosis
a
a
PROUS SCIENCE
(Spain)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALICAFORSEN;
ANTISENSE OLIGONUCLEOTIDE;
BETA1 INTEGRIN;
CORTICOSTEROID;
ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1;
GI 270384;
INTEGRIN;
INTERCELLULAR ADHESION MOLECULE 1;
ISIS 9125;
MLN 02;
MONOCLONAL ANTIBODY;
NATALIZUMAB;
PLACEBO;
TR 14035;
UNCLASSIFIED DRUG;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROHN DISEASE;
DEMYELINATING DISEASE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG SAFETY;
ENTERITIS;
GASTROINTESTINAL DISEASE;
HEADACHE;
HUMAN;
HUMAN CELL;
INFLAMMATORY DISEASE;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
MULTIPLE SCLEROSIS;
NAUSEA;
NEUROLOGIC DISEASE;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
ULCERATIVE COLITIS;
URTICARIA;
|
EID: 0033739275
PISSN: 03778282
EISSN: None
Source Type: Journal
DOI: 10.1358/dof.2000.025.09.593332 Document Type: Review |
Times cited : (5)
|
References (31)
|